Resistell News:

Resistell again among TOP 10 best Swiss startups 2021

Resistell again among TOP 10 best Swiss startups 2021
Resistell News:

Resistell again among TOP 10 best Swiss startups 2021

Resistell joined the TOP100 Best Swiss Start-ups ranking three years ago. This year ranked 9th, staying in the league of TOP10 most promising start-ups in Switzerland in 2021.
Resistell again among TOP 10 best Swiss startups 2021
curves

Latest news

“We Are Losing Our Strongest Allies Against Infectious Diseases” - Dr. Alexander Sturm for European Biopharmaceutical Review (EBR)
image source: European Biopharmaceutical Review
8th September 2021

“We Are Losing Our Strongest Allies Against Infectious Diseases” - Dr. Alexander Sturm for European Biopharmaceutical Review (EBR)

To learn more about how antibiotic resistance and antibiotic tolerance are hindering our ability to slow the spread of infectious diseases read an excellent review article in EBR by Dr. Alex Sturm, Senior Scientist at Resistell.
25th June 2021

Resistell technology featured in "Die Zeit" magazine

The Resistell's device tests antibiotic resistance faster than ever before. A drop of bacteria is placed on a tip of cantilever sensor which records nano-scale vibrations of living cells. The measurements reveal whether an antibiotic worked or the microbes are still alive.
Resistell AG announces start of Performance Evaluation Study
16th June 2021

Resistell AG announces start of Performance Evaluation Study

Resistell AG has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne University Hospital (CHUV)
Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung
15th February 2021

Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung

How do you find the most effective antibiotic for a patient as quickly as possible? The start-up "Resistell" has developed a new type of test for antibiotic resistance. Read more about this test in Schwizerische Ärztezeitung.
International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka
11th February 2021

International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka

On the International Day of Women and Girls in Science, European Innovation Council invited Danuta Cichocka, Resistell CEO, the female scientist and entrepreneur, to share her story about her passion in life science in an interview.
Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?
10th February 2021

Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?

Die Covid-Pandemie hat alle Bereiche des Lebens erfasst. Auch die Startup- und Gründerszene musste mit der Situation umgehen und unter erschwerten Bedingungen die Projekte weiter führen und antreiben. Gleichzeitig aber hat Corona als Katalysator gewirkt für disruptive Ideen, für Innovation und Unternehmergeist.
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
7th January 2021

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.
19th November 2020

Antimicrobials: handle with care by HEMEX

The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.
Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020
16th November 2020

Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020

Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.
Resistell among TOP 10 best start-ups in Switzerland
9th September 2020

Resistell among TOP 10 best start-ups in Switzerland

This year we’ve made a spectacular leap and **ranked 8th**, joining the league of TOP10 most promising start-ups in Switzerland in 2020.
Resistell technology in Frontiers in Mechanical Engineering
29th July 2020

Resistell technology in Frontiers in Mechanical Engineering

Nanomechanical Sensors as a Tool for Bacteria Detection and Antibiotic Susceptibility Testing
Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC
3rd July 2020

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection
19th June 2020

Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection

We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.